Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bonesupport Banks In More Cash, Pharma Expertise For Bioceramic Bone

Executive Summary

Bone substitute materials specialist Bonesupport has strengthened its cash position with an influx of new capital, as well as installed a new chairman to strengthen its pharma know-how as it seeks to grow its drug-eluting bone scaffold business.

You may also be interested in...

Bonesupport Primed For Nasdaq Stockholm Flotation

Swedish orthobiologics company Bonesupport is seeking to raise SEK500m ($45m) by floating its shares publicly for the first time on the Nasdaq Stockholm stock exchange. Proceeds from the IPO will go towards advancing sales of its existing bone substitute products and conducting a major study to gain US approval of antibiotic-eluting bone filler Cerament G.

Bonesupport Brings In Former DePuy Exec As Head of North American Sales

Bonesupport has appointed a new general manager to oversee sales in North America as it steps up commercial efforts of its Cerament bone void filler platform.

VC Deals Analysis: Little Hope Of Recovery As October Plummets

The final quarter of 2016 has not got off to a good start with venture capital funding levels hitting an all-year low in October. Chances of a last-minute turnaround looks increasingly unlikely.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts